Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-25-031991

President/CEO bought 5,500 shares at an average $1.84 ($10,110)

From the SEC's structured data for this filing

Trades in this filing

Gilad Oren · President/CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-04-03 Purchase : show line 1 in the form +3,003 $1.87 $5,616 343,123 D
2025-04-03 Purchase : show line 2 in the form +2,497 $1.80 $4,495 345,620 D
Open-market purchases · 5,500 sh · avg $1.84 · $10,110
Loading xslF345X05/tm2511518-1_4seq1.xml…